Company Overview

Ascend Wellness Holdings, Inc. (CSE: AAWH.U / OTCQX: AAWH) is a vertically integrated cannabis operator focused on the cultivation, manufacturing, distribution, and retail sale of cannabis products in the United States. The company operates in the regulated medical and adult-use cannabis industries and generates revenue primarily through wholesale cannabis distribution and retail dispensary sales. Ascend Wellness serves both medical cannabis patients and adult-use consumers through a portfolio of dispensaries and branded cannabis products across multiple U.S. states.

The company’s core business lines include cannabis cultivation facilities, processing and manufacturing operations, and retail dispensaries operating under the Ascend, Ascend Outlet, and related retail banners. Its product portfolio includes flower, vapes, edibles, concentrates, and wellness-oriented cannabis products sold through both company-owned stores and third-party dispensaries. Ascend Wellness was founded in 2018 and expanded rapidly through acquisitions, state license wins, and facility development in limited-license cannabis markets. The company has positioned itself around scale in densely populated eastern U.S. states, with a strategy emphasizing vertical integration, operational efficiency, and exposure to markets transitioning from medical-only to adult-use cannabis sales.

Business Operations

Ascend Wellness operates through integrated cannabis business units that include cultivation, manufacturing, wholesale distribution, and retail dispensaries. The company’s operations are concentrated in limited-license states including Illinois, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania. Revenue is generated through direct-to-consumer retail sales and wholesale distribution of branded cannabis products to third-party operators. Retail operations are a significant revenue driver due to higher margins associated with vertically integrated sales channels.

The company controls indoor cultivation facilities, processing laboratories, and manufacturing assets used to produce a range of cannabis products under proprietary and partner brands. Ascend Wellness has developed cultivation and processing infrastructure designed to support scaled production in regulated state markets. The company has also entered strategic relationships with local operators and maintains subsidiaries tied to state-specific licensing structures required under U.S. cannabis regulations. Public filings and investor materials identify continued investment in cultivation expansion and retail optimization as central to operational execution.

Strategic Position & Investments

Ascend Wellness has focused its strategy on building a concentrated footprint in populous eastern and midwestern U.S. cannabis markets where regulatory frameworks limit competition through capped licensing systems. The company has historically pursued acquisitions and asset expansion to increase market share and improve vertical integration. Major historical transactions include the acquisition of MedMen New York assets and investments in cultivation and retail infrastructure across New Jersey and Illinois. The company has also expanded selectively through new dispensary openings and cultivation capacity upgrades.

The company’s strategic direction has emphasized operational efficiency, adjusted EBITDA generation, and long-term positioning for broader U.S. cannabis legalization trends. Ascend Wellness has invested in branded product development and expanded manufacturing capabilities for derivative products such as edibles and concentrates. Management commentary in public filings has also highlighted opportunities tied to adult-use market transitions, particularly in northeastern U.S. states. While the company remains focused on cannabis operations, public disclosures do not indicate material diversification into unrelated sectors or emerging technologies outside regulated cannabis production and retail.

Geographic Footprint

Ascend Wellness Holdings is headquartered in New York, New York, and operates primarily within the United States. Its largest operational presence is concentrated in the Midwest and Northeastern United States, including major cannabis markets such as Illinois, Michigan, Massachusetts, New Jersey, Ohio, and Pennsylvania. The company’s footprint includes cultivation facilities, manufacturing centers, and retail dispensaries distributed across these regulated state markets.

The company does not currently maintain significant international operating infrastructure based on publicly available disclosures. Its market presence is centered on U.S. state-level cannabis markets with differing regulatory structures governing medical and adult-use sales. Ascend Wellness has strategically prioritized states with large population bases, limited-license systems, and expanding adult-use legalization frameworks to support long-term revenue growth and operational scale.

Leadership & Governance

Ascend Wellness was co-founded by entrepreneurs and cannabis industry operators seeking to build a vertically integrated multistate cannabis company focused on regulated U.S. markets. The company’s governance structure includes executive leadership with backgrounds in finance, operations, consumer products, and regulated industries. Public company governance is overseen through a board structure aligned with Canadian public market listing requirements and U.S. cannabis regulatory obligations.

The company’s leadership has consistently emphasized disciplined expansion, operational efficiency, and positioning in high-demand limited-license markets. Executive leadership identified in recent public disclosures includes:

• John Hartmann – Chief Executive Officer
• Mark Cassebaum – Chief Financial Officer
• Frank Perullo – President
• Shaleen Title – Board Member
• Andrea Cabral – Board Member

Leadership commentary in investor materials and regulatory filings has highlighted a focus on profitability, disciplined capital allocation, and strengthening retail and cultivation performance in core operating states. Data regarding certain historical executive roles and board composition may vary across reporting periods due to management transitions and governance updates reflected in public filings.